IncellDx

IncellDx is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as COVID-19, HIV/AIDs, lung cancer, breast cancer, bladder cancer, HPV/cervical cancer, head and neck cancer, ovarian cancer, hepatitis, and organ transplant infections. Our proprietary diagnostic method provides specific molecular details about each and every cell. This technology now made available through IncellDx, is capable of revolutionizing the field of molecular diagnostics, one cell at a time

In vitro diagnostics,molecular diagnostics,biotechnology,pathology,hpv,infectious disease,hiv/aids,cervical cancer,immunology,covid-19,bladder cancer,lung cancer,breast cancer,head and neck cancer,circulating tumor cells,and coronavirus

Incelldx operates in the Biotechnology research industry.

Incelldx's revenue is 11m - 100m

Incelldx has 11 - 50 employees.